Glaukos Corp (GKOS) - News Archive

In a significant stride towards enhancing ophthalmic care, Glaukos Corporation (NYSE: GKOS), a leading player in the medical technology and pharmaceutical landscape, recently announced the FDA s approval of its New Drug...

In a bold move underscoring its commitment to advancing ophthalmic healthcare, Glaukos Corporation has taken substantial steps to enhance both its operational capacity and its sustainable practices. Known for its ground...

Glaukos Corporation Breaks New Ground in Ophthalmic Treatment with Epioxa In a significant advancement for the treatment of keratoconus, Glaukos Corporation (NYSE: GKOS) has announced highly encouraging topline results...

Glaukos Corporation s Strategic Exchange Agreements Pave the Path for Growth and SuccessALISO VIEJO, Calif. - Glaukos Corporation (NYSE: GKOS), the renowned ophthalmic pharmaceutical and medical technology company, has...

Aliso Viejo, Calif. Glaukos Corporation (NYSE: GKOS), a leading ophthalmic medical technology and pharmaceutical company specializing in innovative therapies for glaucoma, corneal disorders, and retinal diseases, has an...

Glaukos Corporation Receives FDA Approval for iDose TR, Presenting Positive Growth Prospects in the Glaucoma MarketGlaukos Corporation, a leading ophthalmic medical technology and pharmaceutical company specializing in...